Good Manufacturing Practices ensure products are produced and controlled to the appropriate quality standards while adhering to industry regulations. Resolving and preventing compliance issues for medical products requires expertise in planning, developing, and implementing Good Manufacturing Practice (GMP) quality systems.
Our quality professionals bring direct experience in pharmaceutical, biotechnology, combination, and medical device development and manufacturing to help you understand and address quality assurance needs at every stage of product development.
Our team works closely with your staff to improve processes for manufacturing, distribution, and packaging facilities.
Our quality professionals take the lead in planning, executing, and analyzing comprehensive audits to uncover potential deficiencies and make the necessary improvements, all while empowering your staff to maintain compliance well into the future.
Learn more about our GMP auditors » Learn more about our mock FDA inspection services »
Our GMP Drug Audits focus on pharmaceutical manufacturing facilities, ensuring compliance with FDA regulations for drug products. We evaluate of compliance with 21 CFR Parts 210 and 211, assess of quality management systems, review production and process controls, examine laboratory controls and records, and evaluate of packaging and labeling operations.
Specific areas of focus include, but are not limited to:
Our GMP Device Audits are tailored to medical device manufacturers, ensuring compliance with FDA regulations and international standards. We evaluate compliance with 21 CFR Part 820 (Quality System Regulation), assess design controls and risk management, review production and process controls, examine CAPA systems, evaluate supplier management processes, and more.
Specific areas of focus include, but are not limited to:
Our GMP Biologics Audits focus on the unique challenges of biological product manufacturing, ensuring compliance with FDA regulations and international standards. We assess compliance with 21 CFR Parts 600-680, evaluate cell culture and fermentation processes, review purification and formulation procedures, examine viral clearance and biosafety measures, evaluate stability testing programs, and more.
Specific areas of focus include, but are not limited to:
Is your team using Veeva as your eQMS? In addition to conducting audits, we can complete your data entry directly within your Veeva system, saving you significant time and attention.
Our dedicated project support team works directly with our auditors to streamline the process of inputting audit reports into the Veeva platform. We’ll guide your Veeva Administrator through the steps to confer the necessary user permissions in the platform and take care of the audit input on your behalf.
Contact us to learn more about integrating Veeva management into your auditing service so you can focus on your core operations.
Proprietary talent selection of former FDA and industry professionals amplified by a corporate culture of responsiveness and execution.
US Toll-Free: 1-833-FDA-GROUP
International: +001 508 926 8330